Every SEC Form 3/4/5 on record for this filer (CIK 1120477) — 1 issuer, 91 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| PTGX | Protagonist Therapeutics, Inc | President and CEO · Director | 2016-08-10 → 2026-05-14 | 64 | −$41M |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| PTGX | 2026-05-12 | Sell | 75,000 | $100.12 | $8M | 523,478 |
| PTGX | 2026-05-12 | Sell | 75,000 | $100.12 | $8M | 523,478 |
| PTGX | 2026-03-25 | Sell | 54,641 | $101.00 | $6M | 524,938 |
| PTGX | 2026-03-24 | Sell | 59 | $101.00 | $5,959 | 524,938 |
1 of 1 issuers are covered and open a security page; the rest are on file here only.